Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Amantadine hydrochloride by Shinkei Therapeutics for Traumatic Brain Injury: Likelihood of Approval
Amantadine hydrochloride is under clinical development by Shinkei Therapeutics and currently in Phase II for Traumatic Brain Injury. According to...